CIK 0001776985 · Large accelerated filer
BioNTech SE
Sign in to watch- Ticker
- BNTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Germany
- Entity type
- other
- Phone
- 0049613190840
- Business address
- AN DER GOLDGRUBE 12, MAINZ, Germany, 55131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,232,245
- in 14 filings, $84.2M under 10b5-1 plans
Net −$84,232,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-11 | Sahin Ugur Chief Executive Officer | Sale 10b5-1 | −45,000 | $96.93 | $4.4M | 643,209 |
| 2026-09-10 | Sahin Ugur Chief Executive Officer | Sale 10b5-1 | −20,500 | $96.31 | $2.0M | 688,209 |
| 2026-09-09 | Sahin Ugur Chief Executive Officer | Sale 10b5-1 | −36,000 | $97.78 | $3.5M | 708,709 |
| 2026-09-08 | Sahin Ugur Chief Executive Officer | Sale 10b5-1 | −37,000 | $99.20 | $3.7M | 744,709 |
| 2026-09-04 | Sahin Ugur Chief Executive Officer | Sale 10b5-1 | −31,500 | $103.52 | $3.3M | 781,709 |
| 2026-09-03 | Sahin Ugur Chief Executive Officer | Sale 10b5-1 | −45,000 | $102.85 | $4.6M | 813,209 |
| 2026-05-12 | Zapata Gomez Ramon Chief Financial Officer | Grant or award · Option (right to buy) | +18,879 | 18,879 | ||
| 2026-05-12 | Zapata Gomez Ramon Chief Financial Officer | Grant or award · Performance Share Unit | +15,103 | 15,103 | ||
| 2026-05-12 | Jimenez Kylie Chief People Officer | Grant or award · Option (right to buy) | +10,488 | 10,488 | ||
| 2026-05-12 | Jimenez Kylie Chief People Officer | Grant or award · Performance Share Unit | +8,391 | 8,391 | ||
| 2026-05-12 | Ryan James Timothy Patrick See remarks. | Grant or award · Option (right to buy) | +12,586 | 12,586 | ||
| 2026-05-12 | Ryan James Timothy Patrick See remarks. | Grant or award · Performance Share Unit | +10,069 | 10,069 | ||
| 2026-05-12 | Hanekamp Annemarie Chief Commercial Officer | Grant or award · Option (right to buy) | +12,586 | 12,586 | ||
| 2026-05-12 | Hanekamp Annemarie Chief Commercial Officer | Grant or award · Performance Share Unit | +10,069 | 10,069 | ||
| 2026-05-12 | Poetting Sierk Chief Operating Officer | Grant or award · Option (right to buy) | +12,586 | 12,586 | ||
| 2026-05-12 | Poetting Sierk Chief Operating Officer | Grant or award · Performance Share Unit | +10,069 | 10,069 | ||
| 2026-04-22 | Poetting Sierk Chief Operating Officer | Sale 10b5-1 | −50,000 | $110.56 | $5.5M | 399,387 |
Page 2 of 2 · 37 trades